347850 — DND Pharmatech Cashflow Statement
0.000.00%
- KR₩322bn
- KR₩323bn
- KR₩19bn
Annual cashflow statement for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | — | -72,047 | -163,513 | 4,494 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | — | 2,416 | 99,231 | -13,690 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -48,580 | 5,785 | -2,541 | -4,350 |
Change in Accounts Receivable | ||||
Change in Other Assets | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -48,580 | -51,945 | -53,083 | -9,117 |
Capital Expenditures | -3,108 | -2,218 | -719 | -45.2 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | -225 | 263 | 240 | 313 |
Sale of Fixed Assets | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -3,333 | -1,955 | -479 | 268 |
Financing Cash Flow Items | — | 9,077 | 3,217 | -4.67 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 106 | 67,692 | 1,986 | -630 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -52,446 | 15,346 | -50,454 | -9,862 |